218 related articles for article (PubMed ID: 30335797)
21. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
22. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
24. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
26. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
Crosby JA; Kachlany SC
Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
[TBL] [Abstract][Full Text] [Related]
27. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
28. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
[TBL] [Abstract][Full Text] [Related]
29. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
[TBL] [Abstract][Full Text] [Related]
30. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
31. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
32. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
[TBL] [Abstract][Full Text] [Related]
33. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
Velusamy SK; Sampathkumar V; Godboley D; Fine DH
PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
[TBL] [Abstract][Full Text] [Related]
34. Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.
Walters MJ; Brown AC; Edrington TC; Baranwal S; Du Y; Lally ET; Boesze-Battaglia K
Mol Oral Microbiol; 2013 Oct; 28(5):342-53. PubMed ID: 23678967
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of Size and Toxin Distribution in
Nice JB; Collins SM; Agro SMJ; Sinani A; Moros SD; Pasch LM; Brown AC
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535804
[No Abstract] [Full Text] [Related]
36. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
37. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
Johansson A
Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
[TBL] [Abstract][Full Text] [Related]
38. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
[TBL] [Abstract][Full Text] [Related]
39. Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.
Skals M; Bjaelde RG; Reinholdt J; Poulsen K; Vad BS; Otzen DE; Leipziger J; Praetorius HA
J Biol Chem; 2014 Jul; 289(27):19098-109. PubMed ID: 24860098
[TBL] [Abstract][Full Text] [Related]
40. Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesis.
Isaza MP; Duncan MS; Kaplan JB; Kachlany SC
Infect Immun; 2008 Aug; 76(8):3561-8. PubMed ID: 18541661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
